Screening for colorectal cancer - Now and the near future

被引：13

作者：

Bromer, MQ

Weinberg, DS

机构：

[1] Fox Chase Canc Ctr, Gastroenterol Sect, Philadelphia, PA 19111 USA

[2] Temple Univ, Sch Med, Div Gastroenterol, Philadelphia, PA 19122 USA

[3] Temple Univ, Sch Med, Dept Med, Philadelphia, PA 19122 USA

来源：

SEMINARS IN ONCOLOGY | 2005年 / 32卷 / 01期

关键词：

D O I：

10.1053/j.seminoncol.2004.09.031

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

When used appropriately, screening for colorectal cancer (CRC) can reduce disease-related morbidity and mortality. Current methods include fecal occult blood testing (FOBT), flexible sigmoidoscopy [FS], barium enema, and colonoscopy; all are cost-effective techniques. Unfortunately, offering an array of options has not increased screening utilization, which continues to lag behind that of other common cancers. Newer techniques, particularly virtual colonoscopy (VC) and stool DNA testing, may offer attractive alternatives for healthcare provider recommendation and patient use. © 2005 Elsevier Inc. All rights reserved.

引用

页码：3 / 10

页数：8

共 66 条

[1] Colorectal cancer screening by detection of altered human DNA in stool: Feasibility of a multitarget assay panel [J].